<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medgen</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинская генетика</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Genetics</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2073-7998</issn><publisher><publisher-name>Publishing House «Genius Media» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.25557/2073-7998.2025.11.137-138</article-id><article-id custom-type="elpub" pub-id-type="custom">medgen-3328</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КРАТКОЕ СООБЩЕНИЕ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>BRIEF REPORT</subject></subj-group></article-categories><title-group><article-title>Ожирение модифицирует влияние полиморфизмов SERBP1 на гемокоагуляцию и стеноз коронарных артерий</article-title><trans-title-group xml:lang="en"><trans-title>Obesity modifies the effects of SERBP1 polymorphisms on hemocoagulation and coronary artery stenosis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шиленок</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shilenok</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>305041, Курск, ул. К. Маркса, д.3</p></bio><bio xml:lang="en"><p>3, K. Marx st., Kursk, 305041</p></bio><email xlink:type="simple">Vladislav.Shilenok93@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО Курский государственный медицинский университет Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Kursk State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>24</day><month>12</month><year>2025</year></pub-date><volume>24</volume><issue>11</issue><fpage>137</fpage><lpage>138</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Шиленок В.В., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Шиленок В.В.</copyright-holder><copyright-holder xml:lang="en">Shilenok V.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.medgen-journal.ru/jour/article/view/3328">https://www.medgen-journal.ru/jour/article/view/3328</self-uri><abstract><p>В патогенезе ишемической болезни сердца (ИБС), развивающейся на фоне прогрессирования атеросклероза, участие молекулярных шаперонов является одним из определяющих факторов. SERBP1 (Hero45), РНК-связывающий белок, недавно был отнесен к новому классу белков Hero с шапероноподобной активностью, что делает его изучение особенно актуальным. В настоящем исследовании 836 пациентов с ИБС были генотипированы по пяти однонуклеотидным полиморфизмам SERBP1 с использованием ПЦР. В данной работе мы сообщаем, что однонуклеотидные полиморфизмы гена SERBP1 у пациентов без ожирения (ИМТ &lt; 30) ассоциированы с повышением международного нормализованного отношения (rs4655707 SERBP1: β = 0,4191 ± 0,1661, Pperm = 0,007; rs6702742 SERBP1: β = 0,4195 ± 0,1719, Pperm = 0,0098) и снижением процента стеноза левой коронарной артерии (rs12561767 SERBP1: β = -1,277 ± 0,4637, Pperm = 0,02; rs6702742 SERBP1: β = -1,277 ± 0,4637, Pperm = 0,02). В совокупности наше исследование предоставляет доказательства того, что SERBP1 может модулировать параметры гемокоагуляции и стеноз у пациентов с ИБС без ожирения.</p></abstract><trans-abstract xml:lang="en"><p>In the pathogenesis of coronary heart disease (CHD), which develops against the background of progression of atherosclerosis, the participation of molecular chaperones is one of the determining factors. SERBP1 (Hero45), an RNA-binding protein, has recently been classified as a new class of Hero proteins with chaperone-like activity, which makes its study particularly relevant. In the present study, 836 patients with CHD were genotyped for five single nucleotide polymorphisms of SERBP1 using PCR. In this study, we report that single nucleotide polymorphisms of the SERBP1 gene in non-obese patients (BMI &lt; 30) are associated with an increase in international normalized ratio (INR) (rs4655707 SERBP1: β = 0.4191 ± 0.1661, Pperm = 0.007; rs6702742 SERBP1: β = 0.4195 ± 0.1719, Pperm = 0.0098) and a decrease in the percentage of left coronary artery (LCA) stenosis (rs12561767 SERBP1: β = -1.277 ± 0.4637, Pperm = 0.02; rs6702742 SERBP1: β = -1.277 ± 0.4637, Pperm = 0.02). Taken together, our study provides evidence that SERBP1 may modulate hemostasis parameters and stenosis in non-obese CAD patients.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>SERBP1</kwd><kwd>hero</kwd><kwd>SNP</kwd><kwd>ишемическая болезнь сердца</kwd><kwd>стеноз</kwd></kwd-group><kwd-group xml:lang="en"><kwd>SERBP1</kwd><kwd>hero</kwd><kwd>SNP</kwd><kwd>coronary artery disease</kwd><kwd>stenosis</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Исследование не получало финансовой поддержки</funding-statement><funding-statement xml:lang="en">This research received no external funding</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Malekmohammad K., Bezsonov E.E., Rafieian-Kopaei M. Role of Lipid Accumulation and Inflammation in Atherosclerosis: Focus on Molecular and Cellular Mechanisms. Front Cardiovasc Med. 2021; 8:707529. https://doi.org/10.3389/fcvm.2021.707529</mixed-citation><mixed-citation xml:lang="en">Malekmohammad K., Bezsonov E.E., Rafieian-Kopaei M. Role of Lipid Accumulation and Inflammation in Atherosclerosis: Focus on Molecular and Cellular Mechanisms. Front Cardiovasc Med. 2021; 8:707529. https://doi.org/10.3389/fcvm.2021.707529</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Shilenok I., Kobzeva K., Stetskaya T., et al. SERPINE1 mRNA Binding Protein 1 Is Associated with Ischemic Stroke Risk: A Comprehensive Molecular–Genetic and Bioinformatics Analysis of SERBP1 SNPs. International Journal of Molecular Sciences.2023; 24:8716. https://doi.org/10.3390/ijms24108716</mixed-citation><mixed-citation xml:lang="en">Shilenok I., Kobzeva K., Stetskaya T., et al. SERPINE1 mRNA Binding Protein 1 Is Associated with Ischemic Stroke Risk: A Comprehensive Molecular–Genetic and Bioinformatics Analysis of SERBP1 SNPs. International Journal of Molecular Sciences.2023; 24:8716. https://doi.org/10.3390/ijms24108716</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Vaughan D.E.) PAI-1 and atherothrombosis. Journal of Thrombosis and Haemostasis. 2005; 3:1879–1883. https://doi.org/10.1111/j.1538-7836.2005.01420.x</mixed-citation><mixed-citation xml:lang="en">Vaughan D.E.) PAI-1 and atherothrombosis. Journal of Thrombosis and Haemostasis. 2005; 3:1879–1883. https://doi.org/10.1111/j.1538-7836.2005.01420.x</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Davenport P., Tipping P.G. The Role of Interleukin-4 and Interleukin-12 in the Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice. The American Journal of Pathology. 2003; 163:1117–1125. https://doi.org/10.1016/S0002-9440(10)63471-2</mixed-citation><mixed-citation xml:lang="en">Davenport P., Tipping P.G. The Role of Interleukin-4 and Interleukin-12 in the Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice. The American Journal of Pathology. 2003; 163:1117–1125. https://doi.org/10.1016/S0002-9440(10)63471-2</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Sennello J.A., Fayad R., Pini M., et al. Interleukin-18, together with interleukin-12, induces severe acute pancreatitis in obese but not in nonobese leptin-deficient mice. Proceedings of the National Academy of Sciences.2008; 105:8085–8090. https://doi.org/10.1073/pnas.0804091105</mixed-citation><mixed-citation xml:lang="en">Sennello J.A., Fayad R., Pini M., et al. Interleukin-18, together with interleukin-12, induces severe acute pancreatitis in obese but not in nonobese leptin-deficient mice. Proceedings of the National Academy of Sciences.2008; 105:8085–8090. https://doi.org/10.1073/pnas.0804091105</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
